Most cited papers from Biokine (Israel)

Biokine (Israel)

What are the most cited papers from Biokine (Israel)?

The most cited paper from Biokine (Israel) is "Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype" (Katia Beider, Hanna Bitner, Merav Leiba et al., 2014), with 171 citations. Next come "A simple and sensitive procedure for measuring isotope fluxes through ion-specific channels in heterogenous populations of membrane vesicles." (141) and "The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression" (115).

Published TypeFieldAccessCitations

Showing 46 of 46 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype Katia Beider, Hanna Bitner, Merav Leiba et al. · Oncotarget Open access	12 Jul 2014	171
2	A simple and sensitive procedure for measuring isotope fluxes through ion-specific channels in heterogenous populations of membrane vesicles. Haim Garty, Bernardo Rudy, STEVEN J. D. KARLISH · Journal of Biological Chemistry Open access	Nov 1983	141
3	The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression Michal Abraham, Shiri Klein, Baruch E. Bulvik et al. · Leukemia	10 Mar 2017	115
4	CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth Katia Beider, Michal Begin, Michal Abraham et al. · Experimental Hematology	6 Dec 2010	91
5	The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma Amnon Peled, Michal Abraham, Irit Mazza Avivi et al. · Clinical Cancer Research	18 Nov 2013	86
6	Reliability of Maximal Voluntary Muscle Strength and Power Testing in Older Men Edward Todd Schroeder, Y. Wang, Carmen Castaneda‐Sceppa et al. · The Journals of Gerontology Series A Open access	May 2007	67
7	Noninvasive neuromodulation in essential tremor demonstrates relief in a sham‐controlled pilot trial Peter T. Lin, Erika K. Ross, Paula Chidester et al. · Movement Disorders Open access	17 Apr 2018	63
8	Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML In Vitro and In Vivo Katia Beider, Merav Darash‐Yahana, Orly Blaier et al. · Molecular Cancer Therapeutics	6 Feb 2014	62
9	Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140 Katia Beider, Elena Ribakovsky, Michal Abraham et al. · Clinical Cancer Research	2 May 2013	62
10	Superfluidity: a flexible functional architecture for 5G networks Giuseppe Bianchi, Erez Biton, Nicola Bléfari-Melazzi et al. · Transactions on Emerging Telecommunications Technologies Open access	27 Jul 2016	60
11	BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐label safety and efficacy phase 2a study Gautam M. Borthakur et al. · Cancer Open access	3 Dec 2020	42
12	The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation Michal Abraham, Katia Beider, Hanna Wald et al. · Leukemia	26 Mar 2009	39
13	Longitudinal Analysis of Lactate Threshold in Male and Female Master Athletes TAYLOR J. MARCELL, Steven A. Hawkins, Kyle M. Tarpenning et al. · Medicine & Science in Sports & Exercise	May 2003	35
14	VTX‐1 Liquid Biopsy System for Fully‐Automated and Label‐Free Isolation of Circulating Tumor Cells with Automated Enumeration by BioView Platform Elodie Sollier‐Christen, Corinne M. Renier, Tal Kaplan et al. · Cytometry Part A Open access	13 Sep 2018	33
15	Novel Method for Detection of Reactive Oxygen Species In Vivo in Human Skeletal Muscle Justin D. La Favor, Ethan J. Anderson, Robert Charles Hickner · Physiological Research Open access	16 Jun 2014	21
16	Automatic Scanning of Interphase FISH for Prenatal Diagnosis in Uncultured Amniocytes Dorit Lev, Michal Daniely, Alex Zudik et al. · Genetic Testing	Mar 2005	20
17	The Peptidic CXCR4 Antagonist, BL-8040, Significantly Reduces Bone Marrow Immature Leukemia Progenitors By Inducing Differentiation, Apoptosis and Mobilization: Results of the Dose Escalation Clinical Trial in Acute Myeloid Leukemia Gautam M. Borthakur, Yishai Ofran, Arnon Nagler et al. · Blood	3 Dec 2015	17
18	The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data Raanan Greenman, Tom Snir, Avi Katav et al. · Cells Open access	23 Jan 2024	15
19	Applicability of the multiple alignment algorithm for detection of weak patterns: periodically distributed DNA pattern as a study case Alexander Bolshoy, Ilya P. Ioshikhes, Edward N. Trifonov · Computer applications in the biosciences	1996	13
20	Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation Michal Abraham, Hanna Wald, Dalit Vaizel-Ohayon et al. · Frontiers in Immunology Open access	23 Nov 2017	12
21	Ad Libitum vs. Restricted Fluid Replacement on Hydration and Performance of Military Tasks Heinrich W. Nolte, Timothy David Noakes, Kim Nolte · Aviation Space and Environmental Medicine Open access	29 Jan 2013	12
22	31P-NMR and Differential Scanning Calorimetry Studies for Determining Vesicle’s Drug Physical State and Fraction in Alendronate Liposomes Eyal Afergan, Yousef Najajreh, Dikla Gutman et al. · Journal of Bioanalysis & Biomedicine Open access	2010	11
23	Assessing the quality and quantity of social interaction in a socially assistive robot-guided therapeutic setting Eric Wade, John M. Dye, Ross Mead et al. Conference paper	Jun 2011	11
24	CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms Raanan Greenman, Chris J. Weston · Cells ReviewOpen access	13 Jan 2025	9
25	Machine Learning Identifies Key Proteins in Primary Sclerosing Cholangitis Progression and Links High CCL24 to Cirrhosis Tom Snir, Raanan Greenman, Revital Aricha et al. · International Journal of Molecular Sciences Open access	30 May 2024	9
26	Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment Shira Hagbi-Levi, Michal Abraham, Liran Tiosano et al. · Journal of Immunology Research Open access	5 Aug 2019	9
27	REBT with Ageing Populations Ruth Malkinson, Liora Bar-Tur Book chapter	2019	9
28	Natural and induced immunization against CCL20 ameliorate experimental autoimmune encephalitis and may confer protection against multiple sclerosis Michal Abraham, Arnon Karni, Karin Mausner-Fainberg et al. · Clinical Immunology	20 Sep 2017	8
29	Sequential administration of the high affinity CXCR 4 antagonist BKT 140 promotes megakaryopoiesis and platelet production Michal Abraham, Ido D. Weiss, Hanna Wald et al. · British Journal of Haematology	Aug 2013	7
30	Locomotor Biomechanics After Total Sacrectomy Jo Armour Smith, Alexander Tuchman, Michael Huoh et al. · Spine	9 Sep 2014	6
31	Function-modulating human monoclonal antibodies against platelet-membrane receptors isolated from a phage-display library Y Hagay, Judith Lahav, AVIGDOR LEVANON et al. · Journal of Thrombosis and Haemostasis Open access	31 Jul 2003	6
32	The Selective Anti Leukemic Effect of BL-8040, a Peptidic CXCR4 Antagonist, Is Mediated By Induction of Leukemic Blast Mobilization, Differentiation and Apoptosis: Results of Correlative Studies from a Ph2a Trial in Acute Myeloid Leukemia Gautam M. Borthakur et al. · Blood	2 Dec 2016	5
33	The CXCR4 Antagonist BL-8040 Efficiently Induces Apoptosis and Inhibits The Survival Of AML Cells Sigal Tavor, Ido D. Weiss, Katia Beider et al. · Blood	15 Nov 2013	5
34	Mode of Action of RZL-012, a New Fat-Reducing Molecule Eran Blaugrund, Racheli Gueta, Anton Zernov et al. · Dermatologic Surgery Open access	9 Sep 2021	4
35	REBT and Complicated Grief Ruth Malkinson Book chapter	2019	2
36	CXCR4 Antagonist BKT140 Synergizes with Rituximab, Targeting Non Hodgkin Lymphoma (NHL) In Vitro and In Vivo in a Xenograft Model with Bone Marrow Involvement Katia Beider, Elena Ribakovsky, Michal Abraham et al. · Blood	18 Nov 2011	2
37	Safety and Effectiveness of Naproxen 220mg + Paracetamol 300mg + Pamabrom 25mg Fixed Dose Combination in Women With Premenstrual Syndrome: A Post-marketing, Open-Label, Prospective, Multicenter, Observational Study Álvaro E. Peña-Jiménez, Omar Benítez-Aguilar, Jesús E. Villegas et al. · Preprints.org PreprintOpen access	Aug 2023	1
38	Training and Competition Loads in Women’s Rugby Sevens Athletes: Are There Implications for Cardiovascular Health? Luca Napoli, Stuart Semple, Andrew J. McKune · International Journal of Sports Physiology and Performance Open access	25 Jul 2023	1
39	Anti-Leukemia and Multiple Myeloma Selective Activity of CXCR4 Antagonist 4F-Benzoyl-TN14003 Involves Apoptotic Death Pathway. Katia Beider, Michal Begin, Michal Abraham et al. · Blood	20 Nov 2009	1
40	A randomized, double-blind, single dose, parallel group, 2-arm study assessing the pharmacokinetic similarity, safety, tolerability, and immunogenicity profiles of biosimilar candidate AVT03 (70 mg/mL) in healthy male adults Monika Tomaszewska-Kiecana, Felicitas Bullo, Łukasz Jaśkiewicz et al. · Expert Opinion on Investigational Drugs Open access	13 May 2025	0
41	Bioequivalence Studies of Rivaroxaban at Two Different Strengths: Rivaroxaban 10 mg under Fasting Conditions and Rivaroxaban 20 mg under Fed Conditions in Healthy Mexican Subjects Mario González-de la Parra, Piñeyro-Garza E, Gómez-Silva M et al. · Bioequivalence & Bioavailability International Journal Open access	26 Sep 2023	0
42	Immunization against CCL20, aTh17 cell related chemokine, may confer protection against multiple sclerosis (MS). (P2.368) Arnon Karni, Michal Abraham, Karin Mausner-Fainberg et al. · Neurology	18 Apr 2017	0
43	The High Affinity CXCR4 Inhibitor, BL-8040, Induces Apoptosis of AML Blasts and Their Terminal Differentiation By Blocking AKT/ERK Survival Signals and Downregulating BCL-2, MCL-1 and Cyclin-D1 through Regulation of Mir-15a/16-1 Expression Michal Abraham, Shiri Klein, Baruch E. Bulvik et al. · Blood	2 Dec 2016	0
44	S1P Modulator FTY720 Targets Multiple Myeloma Cell Proliferation and Stromal Interactions Via CXCR4/CXCL12 and mTOR Pathways Katia Beider, Evgenia Rosenberg, Hanna Bitner et al. · Blood	6 Dec 2014	0
45	BL-8040, a CXCR4 antagonist, synergizes with the FLT3 inhibitor AC220 inducing apoptosis and reducing minimal residual disease to prolong survival of AML diseased mice Yaron Pereg, Hanna Wald, Orly Eizenberg et al. · Clinical Lymphoma Myeloma & Leukemia	Jun 2015	0
46	BL-8040, A novel CXCR4 inhibitor, affects AML blasts survival and induces their terminal differentiation Michal Abraham, Ahmed Al-Rawi, Yaron Pereg et al. · Clinical Lymphoma Myeloma & Leukemia	Sep 2015	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.